Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


TechniScan promotes Dr Pepper

This article was originally published in Clinica

Executive Summary

Ultrasound specialist TechniScan Medical Systems has elected Joe Pepper chairman of its board of directors. Dr Pepper is already a member of the firm's board, and currently also acts as a consultant for medical device start-ups. He was previously CEO of automated breast ultrasound specialist U-Systems, and held the same position at OEC Medical Systems, which was acquired by GE Healthcare in 1999 (, 16 August 1999). He also worked for The BOC Group as president of its Ohmeda Medical Devices subsidiary. Dr Pepper replaces previous chairman Ken Hungerford, who held the position since 2009, when Salt Lake City, Utah-based TechniScan became a publicly listed company. The firm's flagship product, the Svara Warm Bath Ultrasound, is designed to improve patient comfort during breast ultrasound procedures. TechniScan is currently in the process of applying for 510(k) clearance for the product from the US FDA.

You may also be interested in...

What are the hottest innovations from Israel?

Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.

EuroPCR: St Jude and Philips talk up rival intravascular imaging techs

St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.

EuroPCR: Medtronic's drug-coated balloon keeps rising

A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts